ADvantage Therapeutics has filed a notice of an exempt offering of securities to raise $25,449,956.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ADvantage Therapeutics is raising $25,449,956.00 in new funding. Sources indicate that as part of senior management Chairman, Agustin Santana played a key role in securing…